Euretina 2026

Adaptive optics (AO) retinal imaging and biomarkers enable new discoveries in disease pathophysiology and can de-risk the development of retinal therapies, from inherited retinal diseases to non-ophthalmic systemic diseases.

Imagine Eyes will promote AO imaging at the 26th Euretina Congress meeting in Vienna on October 1-4, 2026, booth F21.

Investigators

Interested in learning how ultrahigh-resolution AO retinal imaging can benefit clinical research in IRDs, non-exudative AMD, hypertension and more? Curious about AI-powered AO retinal biomarkers for natural history studies?

Stop by Imagine Eyes’ booth F21 and discover our latest innovations:

Meet the team and let’s talk about what cellular-level retinal imaging can do for your clinical research !

Schedule your meeting at Euretina

 

Trial sponsors and CROs

We offer global services for a successful implementation of AO biomarkers in natural history studies and clinical trials, thanks to the global clinical trial equipement network of our partner Emsere.

Visit us at Euretina to discuss how to de-risk your development programs for retinal degenerations.

 

Schedule your meeting at Euretina